Skip to main content
Signal8

Keenan Greg

SEC insider (Form 3/4/5 filer). CIK 0002044006. Chief Medical Officer at Jasper Therapeutics, Inc. (JSPR) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 6, 2026. Located in EDMONTON, A0.

Companies Keenan Greg has filed insider reports for

  • Jasper Therapeutics, Inc. (JSPR): Officer, Chief Medical Officer
  • Aurinia Pharmaceuticals Inc. (AUPH): Officer, SVP, Chief Medical Officer
Keenan Greg profile photo

Keenan Greg

CIK: 0002044006

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Officer
Aurinia Pharmaceuticals Inc. logo
AUPH

Aurinia Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Mar 6, 2026
    Tax Payment
    Direct
    8.1K shares at avg. $14.32$116K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Feb 27, 2026
    Award
    Direct
    40.6K shares-
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Feb 2, 2026
    Tax Payment
    Direct
    11.6K shares at avg. $14.53$168K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Aug 1, 2025
    Sale
    Direct
    20K shares at avg. $10.50$210K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Mar 7, 2025
    Sale
    Direct
    8.3K shares at avg. $8.23$68K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Mar 3, 2025
    Sale
    Direct
    12.2K shares at avg. $8.00$98K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Feb 28, 2025
    Award
    Direct
    62.6K shares-

1-7 of 7